Literature DB >> 28323932

Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.

Hyemi Kwon1,2, Hye-Seon Oh1, Mijin Kim1, Suyeon Park1, Min Ji Jeon1, Won Gu Kim1, Won Bae Kim1, Young Kee Shong1, Dong Eun Song3, Jung Hwan Baek4, Ki-Wook Chung5, Tae Yong Kim1.   

Abstract

Context: Papillary thyroid microcarcinoma (PTMC) usually has an excellent prognosis. Objective: To evaluate the three-dimensional structures of PTMCs, using serial neck ultrasonography (US) in patients under active surveillance. Design and Setting: A retrospective cohort study. Participants: In total, 192 patients diagnosed with PTMC under active surveillance for >1 year were included in a median 30-month follow-up. Changes in tumor size were evaluated not only using the maximal tumor diameter but also the tumor volume.
Results: The median age of patients was 51.3 years and 145 patients (76%) were female. The median initial maximal tumor diameter and tumor volume were 5.5 mm and 48.8 mm3, respectively. The tumor size increased in 27 patients (14%); 23 patients showed a tumor volume increase >50% without a maximal diameter increase of ≥3 mm. The other four patients had both an increasing tumor volume and increasing maximal tumor diameter ≥3 mm. One patient (0.5%) had newly appeared cervical lymph node (LN) metastasis at 3 years after the initial diagnosis. There were no significant risk factors associated with increased tumor size, such as age, sex, or Hashimoto thyroiditis. Twenty-four patients (13%) underwent delayed thyroid surgery at a median of 31.2 months and seven (29%) had cervical LN metastasis on pathologic examination.
Conclusion: Some PTMCs could grow significantly after a relatively short period of active surveillance. We also found that the change in tumor volume was more sensitive to detect tumor progression than the change in the maximal tumor diameter.
Copyright © 2017 Endocrine Society

Entities:  

Mesh:

Year:  2017        PMID: 28323932     DOI: 10.1210/jc.2016-4026

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-up.

Authors:  R Michael Tuttle; Ali S Alzahrani
Journal:  J Clin Endocrinol Metab       Date:  2019-03-15       Impact factor: 5.958

Review 2.  [Surgery of papillary thyroid microcarcinoma].

Authors:  T Weber; S Peth; R Hummel
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

Review 3.  Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence.

Authors:  Yuyang Ze; Xiaowen Zhang; Fei Shao; Lin Zhu; Shanmei Shen; Dalong Zhu; Yan Bi
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-30       Impact factor: 4.553

Review 4.  Active Surveillance of Papillary Thyroid Microcarcinoma: Where Do We Stand?

Authors:  Min Ji Jeon; Won Gu Kim; Ki-Wook Chung; Jung Hwan Baek; Won Bae Kim; Young Kee Shong
Journal:  Eur Thyroid J       Date:  2019-09-25

5.  Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.

Authors:  Allen S Ho; Michael Luu; Cynthia Zalt; Luc G T Morris; Irene Chen; Michelle Melany; Nabilah Ali; Chrysanta Patio; Yufei Chen; Jon Mallen St-Clair; Glenn D Braunstein; Wendy L Sacks; Zachary S Zumsteg
Journal:  Thyroid       Date:  2019-09-24       Impact factor: 6.568

Review 6.  How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.

Authors:  Kennichi Kakudo
Journal:  Gland Surg       Date:  2018-08

7.  Multifocality and Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.

Authors:  Ryuta Nagaoka; Aya Ebina; Kazuhisa Toda; Tomoo Jikuzono; Marie Saitou; Masaomi Sen; Hiroko Kazusaka; Mami Matsui; Keiko Yamada; Hiroki Mitani; Iwao Sugitani
Journal:  World J Surg       Date:  2021-06-07       Impact factor: 3.352

8.  Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.

Authors:  Min Ji Jeon; Sung Min Chun; Ji-Young Lee; Kyeong Woon Choi; Deokhoon Kim; Tae Yong Kim; Se Jin Jang; Won Bae Kim; Young Kee Shong; Dong Eun Song; Won Gu Kim
Journal:  Endocrine       Date:  2019-01-15       Impact factor: 3.633

9.  European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions.

Authors:  Giovanni Mauri; Laszlo Hegedüs; Steven Bandula; Roberto Luigi Cazzato; Agnieszka Czarniecka; Oliver Dudeck; Laura Fugazzola; Romana Netea-Maier; Gilles Russ; Göran Wallin; Enrico Papini
Journal:  Eur Thyroid J       Date:  2021-05-25

10.  The relationship between lipotoxicity and risk of extrathyroidal extension in papillary thyroid microcarcinoma.

Authors:  Changlin Li; Haixia Guan; Qiao He; Yishen Zhao; Nan Liang; Jiao Zhang; Gianlorenzo Dionigi; Hui Sun
Journal:  Endocrine       Date:  2021-06-30       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.